Shilpa Medicare share price surged after the company said that its arm, Shilpa Pharma Lifesciences, has received certificate of suitability (CEP) from EDQM for API, Desmopressin
Lupin is preparing the launch of PredForte, having a market of $200 million with 180 days competitive generic therapy (CGT) exclusivity in the near term
Axis Bank Q3 result review: Axis Bank's is moving in the right direction with improvement in net interest margins, sustaining loan growth momentum, and expansion in return profile, analysts said
Stocks to watch today: Sebi has acceded to the central government's request to reclassify its shareholding in IDBI Bank after its disinvestment as "public holding"
They could replace Piramal Enterprises, Gland Pharma, Mphasis, Muthoot Finance, Bandhan Bank and Paytm, which may move to mid-cap space, reveals analysis by Brian Freitas of Periscope Analytics
Stocks to watch today: IT behemoth Tata Consultancy Services (TCS) is slated to report June quarter 2022 numbers (Q1FY23); Dr Reddy's received two observations from USFDA for its Andhra plant
Stocks to Watch: Titan on Wednesday said its sales in the April-June quarter were up nearly three-fold on a year-on-year basis, helped by a low base of the Covid-19 impacted quarter in the last year.
Reliance Industries shares gained as much as Rs 32.9, or 1.4 per cent intraday, on the BSE on Monday, before finally closing trade at Rs 2,413.95 apiece
According to Mehul Kothari of Anand Rathi, traders can accumulate V-Guard Industries share in the range of 222 - 218 with a stop loss of 210 for an upside target of 236 in coming 1 - 2 weeks.
The Indian benchmarks are set to climb higher in 2022. Though there can be intermittent corrections, the broad trend remains up. Here is how key indices are stacked up the on technical charts
